A real-world study presented at finds zuranolone's PPD symptom improvements were sustained through day 90.
|Articles|February 3, 2023
VEC offers perspective on “Long COVID” by discussing lingering conditions caused by other viruses and some bacteria
Advertisement
Although “Long COVID” is affecting the lives of many, the notion that people would have lingering symptoms after an infection is not new. Indeed, both viral and bacterial infections can change the course of one’s life. It is something that the VEC heard in
Recently, the VEC described other infections that are known for their lingering symptoms, theories about why this happens, and what the current thinking is related to COVID-19.
Advertisement
Related to this article
Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.
Maternal RSV immunization creates an important opportunity for obstetric and pediatric clinicians to coordinate newborn prevention strategies, according to Kevin Ault, MD.
A new Gallup survey found 51% of women in the United States reported negative healthcare experiences.
Hugh Taylor, MD, explains that imaging in endometriosis is best for ruling out other causes of pelvic pain and cannot exclude the diagnosis.
A new study links earlier menopause age to faster cognitive decline and earlier Alzheimer diagnosis.
The FDA office of Women's Health and Center for Drug Evaluation and Research and hosting a public workshop with a focus on testosterone use in menopausal women.
Bruce Dorr, MD, FACOG, URPS, FMCP-M, weighs his own experience with pellet therapy against guideline evidence, then he and Maria Uloko, MD, close with candid advice for clinicians too afraid of hormones to start prescribing.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
FDA holding public meeting on testosterone use in menopausal women
2
Survey: 51% of US-women report negative healthcare experiences
3
Contemporary OB/GYN Weekly Review: Testosterone evidence, ECV counseling, and more
4
Earlier menopause associated with less favorable functional, structural neurological outcomes
5